Tweet
<img alt="" height="1" width="1" />
J&J, Pharmacyclics leukemia drug improves survival in study
Reuters
(Reuters) - An independent committee recommended a late stage trial of a cancer drug developed by Pharmacyclics Inc and Johnson & Johnson be stopped early as it became clear it helped patients with chronic lymphocytic leukemia (CLL) live longer, ...
Pharmacyclics Phase 3 Lymphoma Treatment Study Meets EndpointsWall Street Journal
Wall Street Expects Pharmacyclics Drug's Positive Result To Lead To Off-Label ...Forbes
Pharmacyclics Shares Rise on Positive Leukemia TrialBloomberg
Investor's Business Daily -MarketWatch (blog)
all 16 news articles »
More...